Atia Vision, Inc., a Campbell, Calif.–based company committed to improving patient outcomes through the development of a modular presbyopia-correcting accommodating intraocular lens, held the initial closing of its committed $20M Series D financing.
The round was led by Cormorant Asset Management, with participation from The Capital Partnership (TCP), AMED Ventures and Shangbay Capital.
The company intends to use the funds to advance its clinical efforts.
Led by Mariam Maghribi, President and CEO, Atia Vision is a medical device company formed by Shifamed LLC, a Silicon Valley based medical innovation hub.
The Atia Vision modular intraocular lens technology features an accommodating base responsive to the ciliary muscles, simulating the natural mechanism of the eye and fixed lens element that allows for subsequent refractive correction.